T1 Condition 879 885 tumors
T2 Gene 111 137 site of metastatic disease
T4 Condition 620 626 tumors
T6 Condition 222 228 tumors
T7 Organism 139 147 Patients
T8 Condition 826 831 liver
T10 Condition 216 228 colon tumors
T11 Condition 911 916 liver
T13 Condition 208 228 primary colon tumors
T14 Condition 233 249 liver metastases
T15 Condition 1153 1159 tumors
T16 Condition 1508 1520 colon cancer
T17 Condition 1424 1470 primary tumors and colorectal liver metastases
T18 Protein 447 454 TNFSF14
T19 Condition 1142 1159 metastatic tumors
T20 Level 1298 1304 T-cell
T21 Condition 233 238 liver
T22 Condition 83 88 liver
T23 Condition 808 822 primary tumors
T24 CL 1069 1079 lymphocyte
T25 CL 1050 1080 tumor-infiltrating lymphocytes
T26 CL 1109 1119 lymphocyte
T27 Condition 324 333 antitumor
T29 Condition 483 506 colon cancer metastases
T30 Protein 287 304 molecular factors
T31 Organism 596 602 murine
T32 Condition 1432 1438 tumors
T34 Condition 1424 1438 primary tumors
T35 CL 654 664 lymphocyte
T36 Condition 683 712 tumor cell–specific antitumor
T37 Condition 826 842 liver metastases
T38 Condition 1225 1234 antitumor
T39 Condition 939 980 cytotoxic T-lymphocyte–mediated antitumor
T40 Organism 16 24 patients
T41 CL 174 204 tumor-infiltrating lymphocytes
T42 Organism 16 23 patient
T43 Organism 532 539 patient
T44 Condition 483 495 colon cancer
T45 CL 951 961 lymphocyte
T49 Condition 614 626 colon tumors
T50 CL 193 203 lymphocyte
